Ozempic (semaglutide) was initially approved by the FDA for the management of type 2 diabetes. The FDA expanded the approval of semaglutide (under the brand name Wegovy) for chronic weight management in adults who are either obese or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), in addition to a reduced calorie diet and increased physical activity. This means that semaglutide can be used in non-diabetic patients for weight loss, but it is not intended to be used for cosmetic weight loss in individuals without any associated health risks. It's also important to note that it's not a substitute for healthy lifestyle changes. Diet, exercise, and other lifestyle factors continue to play an essential role in weight management. Remember that all medications, including Ozempic, have potential risks and side effects. It's crucial to discuss these, along with your personal health history and goals, with your healthcare provider before starting any new medication. They can provide guidance on whether a medication like Ozempic might be appropriate and beneficial for you.